Business Context and Reporting Period
This Form 8-K Current Report was filed by Becton, Dickinson and Company (BD) on October 3, 2018, regarding an event that occurred on September 25, 2018, with an effective date of October 1, 2018.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and executive appointments.
Material Changes
The primary material change reported is the appointment of Thomas E. Polen to the additional position of Chief Operating Officer, effective October 1, 2018. Mr. Polen continues to serve as President, a role he has held since April 2017.
Management Commentary and Compensation
In connection with his appointment as Chief Operating Officer, Mr. Polen received increases in his base salary and equity compensation target. The filing notes his prior roles as Executive Vice President and President of the Medical Segment, and previously as Group President.
Investor Verification Checklist
- Confirm the effective date of Thomas E. Polen's appointment as Chief Operating Officer (October 1, 2018).
- Review the specific details of the base salary and equity compensation increases in subsequent proxy statements or compensation reports.
- Verify the current organizational structure to understand the division of duties between the President and the new Chief Operating Officer.